# Prostate Cancer Screening: Understanding Your Options

Prostate cancer screening remains one of medicine's most debated decisions. The American Cancer Society and U.S. Preventive Services Task Force offer different recommendations, leaving men and their doctors to navigate conflicting guidance.

The PSA test (prostate-specific antigen blood test) forms the foundation of most screening programs. It measures a protein produced by the prostate gland. Higher levels can indicate cancer, but the test also triggers false positives. Many detected cancers grow slowly and never cause harm, yet treatment carries real risks including incontinence and erectile dysfunction.

The Task Force reviewed decades of research and concluded that routine PSA screening for men without symptoms causes more harm than benefit for most populations. They recommend against screening men under 55 and suggest shared decision-making for men 55 to 69 who want screening. Men over 70 should not be screened routinely.

The American Cancer Society takes a different stance, recommending that men at average risk begin conversations about screening at age 50. Black men and those with a family history of prostate cancer should discuss screening starting at age 40 or 45, since these groups face higher incidence and mortality rates.

The evidence shows this: screening detects many cancers that would never become life-threatening. Treatment of these indolent cancers exposes men to unnecessary complications. Conversely, some aggressive cancers do benefit from early detection and treatment, particularly in younger men with decades of life ahead.

Your decision depends on personal values. Men who prioritize avoiding unnecessary treatment lean toward limited screening. Those who prefer knowing their status and acting on information often choose screening.

Start by discussing your personal risk with your doctor. Black men and those with affected relatives have legitimately higher stakes. Age matters too. A 50-year-old has more potential benefit from early detection than